Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Your body uses two key hormones—GLP-1 and GIP—to manage hunger, blood sugar, and how fast your stomach empties after meals. When both receptors are activated together, patients in clinical trials experienced weight loss averaging 20% of body weight over 68 weeks, compared to smaller reductions from single-peptide therapy alone.
What Are GLP-1 and GIP Hormones?
GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) are hormones your intestines naturally produce when you eat. Both signal your brain that you are satisfied, slow the rate food moves through your digestive system, and help regulate blood sugar levels after meals. These hormones work through specific receptors in your brain and pancreas, creating multiple pathways that reduce overall calorie intake without requiring willpower alone.
Your genetic makeup determines how sensitive your GLP-1 and GIP receptors are to these natural hormones. Some people inherit variants in the GLP1R gene (such as rs6923761) or the GIPR gene (rs1800437) that reduce receptor responsiveness, making weight management harder even with calorie restriction and exercise. This is why precision testing helps identify whether you have reduced peptide sensitivity before choosing a treatment approach.
Single GLP-1 vs. Dual GLP-1 and GIP Activation
Medications containing only GLP-1 (such as semaglutide) activate one hormone pathway and produce meaningful weight loss for many patients. However, adding GIP activation—the second peptide—engages additional appetite-control and metabolic centers in the brain simultaneously. Research shows that dual-peptide therapy produces approximately 22% greater weight loss than GLP-1-only treatment in the same timeframe, because both hormones amplify satiety and reduce hunger independently.
The difference lies in mechanism: GLP-1 slows stomach emptying and reduces hunger signals in the hypothalamus, while GIP improves how your body uses glucose and may enhance energy expenditure. When both receptors receive activation together, the brain receives redundant 'fullness' signals from multiple pathways, making appetite suppression more durable and less dependent on a single biological channel. PlexusDx Compounded Tirzepatide Injection delivers dual GLP-1/GIP activation in a single weekly injection, starting at $249 per month—your dose may need to go up, but your price won't.
How Genetic Variants Affect Your Peptide Response
Four major genetic variants influence how well GLP-1 and GIP therapy works for your body: the GLP1R rs6923761 variant (affecting GLP-1 receptor sensitivity), GIPR rs1800437 (affecting GIP receptor function), FTO rs9939609 (linked to appetite regulation and fat distribution), and MC4R rs17782313 (involved in satiety signaling). If you carry unfavorable variants in multiple pathways, you may benefit more from dual-peptide therapy or higher doses compared to someone with naturally responsive receptors. Conversely, favorable variants can mean lower doses produce your target weight loss, reducing side effects and costs.
PlexusDx Precision Peptide Genetic Test ($99 add-on after your first treatment month) maps 14 distinct metabolic pathways and 49 peptide-related genes to reveal your specific genetic predispositions. This test is not a pharmacogenomic screening—it analyzes your peptide-pathway genetics directly, helping your PlexusDx clinician predict whether you'll respond best to GLP-1 monotherapy, dual GLP-1/GIP therapy, microdose protocols, or combination approaches tailored to your biology.
Getting Dual-Peptide Therapy Through PlexusDx
PlexusDx Compounded Tirzepatide Injection is manufactured by licensed 503A compounding pharmacies and combines GLP-1 and GIP activation in one weekly subcutaneous injection. The medication is available to patients in all 50 states without insurance requirements, membership fees, or waiting lists—and is HSA/FSA eligible, reducing your out-of-pocket cost. Starting at $249 per month with three commitment tiers ($249, $269, or $289), your monthly price stays flat regardless of dose increases, ensuring predictable costs as your clinician optimizes your treatment.
PlexusDx also offers Compounded Semaglutide Injection (GLP-1 only, from $149/mo) for patients who prefer single-peptide therapy, Oral Tirzepatide for those who prefer capsules, and the Microdose GLP-1 Protocol ($129/mo flat) for individuals seeking gentler appetite suppression. Your PlexusDx clinician will discuss which option aligns with your genetic profile, health history, and lifestyle during your initial consultation, ensuring your precision therapy matches your biology and goals.
Clinical Evidence and Safety Considerations
The landmark SURPASS clinical trial program demonstrated that tirzepatide (dual GLP-1/GIP activation) produced sustained weight loss and improved cardiovascular outcomes in over 13,000 participants across five studies. Participants achieved average weight loss of 20-22% of body weight, with benefits maintained through 2+ years of treatment. Common side effects—nausea, vomiting, constipation, and mild diarrhea—typically decrease after the first 4-8 weeks as your body adjusts, and occur less frequently with lower starting doses or the Microdose GLP-1 Protocol.
Compounded tirzepatide from PlexusDx is produced under 503A pharmacy standards, which require individual patient compounding under a licensed pharmacist's supervision and a valid prescription from your clinician. While compounded medications are not FDA-approved as finished drugs (unlike brand Mounjaro®), 503A compounding is legal, regulated by state pharmacy boards, and covered by most HSA/FSA accounts. PlexusDx clinicians screen for contraindications—personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or severe kidney disease—before initiating therapy to ensure safety.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Why is tirzepatide (dual GLP-1/GIP) more effective than semaglutide (GLP-1 only) for weight loss?
Tirzepatide activates two hunger-control pathways simultaneously, while semaglutide activates only one. Clinical trials show tirzepatide produces approximately 22% greater weight loss than GLP-1-alone therapy because both hormones amplify satiety independently, creating more durable appetite suppression from multiple brain regions.
Can genetic testing predict whether I'll respond to GLP-1 or GIP therapy?
Yes. PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 45 other peptide-pathway genes to reveal your genetic predispositions.
How much does tirzepatide cost at PlexusDx, and will my price go up if my dose increases?
PlexusDx Compounded Tirzepatide Injection starts at $249 per month with three commitment tiers (also $269 and $289/mo). Your monthly price stays completely flat no matter how high your dose goes—we follow the pricing principle: 'Your dose may need to go up. Your price won't.'
What are the most common side effects, and how long do they last?
Nausea, vomiting, constipation, and mild diarrhea are most frequent during weeks 1-4, with most side effects resolving or becoming minimal by weeks 6-8. Starting with a lower dose or choosing PlexusDx Microdose GLP-1 Protocol ($129/mo flat) reduces early side effects by using gentler initiation schedules.
Is PlexusDx compounded tirzepatide safe and legal?
Yes. PlexusDx compounds tirzepatide through licensed 503A compounding pharmacies (never 503B), which are state-regulated and legally authorized to prepare custom medications under a valid prescription.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Finding Your Optimal Path: What Is the Therapeutic Dose of Semaglutide for Effective Weight Management?
How Many People Are Taking Compounded Semaglutide?